Empire Financial Management Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.66M Buy
10,406
+254
+3% +$90.5K 0.83% 37
2025
Q4
$3.32M Buy
10,152
+63
+0.6% +$20K 0.72% 48
2025
Q3
$2.85M Buy
10,089
+235
+2% +$68.2K 0.65% 50
2025
Q2
$2.75M Buy
9,854
+202
+2% +$57.2K 0.79% 38
2025
Q1
$3.01M Buy
9,652
+344
+4% +$102K 0.93% 33
2024
Q4
$2.43M Buy
9,308
+398
+4% +$118K 0.76% 38
2024
Q3
$2.87M Buy
8,910
+911
+11% +$298K 0.88% 32
2024
Q2
$2.5M Buy
7,999
+697
+10% +$205K 0.83% 34
2024
Q1
$2.08M Buy
7,302
+975
+15% +$285K 0.69% 45
2023
Q4
$1.82M Buy
6,327
+92
+1% +$25.1K 0.71% 45
2023
Q3
$1.68M Buy
6,235
+1,454
+30% +$363K 0.73% 45
2023
Q2
$1.06M Buy
4,781
+230
+5% +$53.4K 0.42% 64
2023
Q1
$1.1M Buy
+4,551
New +$1.12M 0.45% 70

Other funds holding AMGN

Empire Financial Management Company's AMGN Position: Q1 2026 in Review

Empire Financial Management Company increased its Amgen (AMGN) stake by 2.5% in Q1 2026, buying an estimated $90.5K and bringing the position to 10,406 shares worth $3.66M. The position accounts for 0.83% of the portfolio, ranked #37.

Empire Financial Management Company first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Empire Financial Management Company held 10,406 shares of Amgen worth $3.66M as of Q1 2026.
  • Empire Financial Management Company bought 254 Amgen shares in Q1 2026, an estimated $90.5K.
  • Amgen made up 0.83% of Empire Financial Management Company's portfolio in Q1 2026, its #37 holding.
  • Empire Financial Management Company first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.